Kymera Therapeutics所有資訊

Kymera Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Atlas Venture Fund X, L.P.(6.4%),Atlas Venture Associates X, L.P.(6.4%)等

11/14 16:36 (美東)

Kymera Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(10.3%)

11/14 13:40 (美東)

Kymera Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Avoro Capital Advisors LLC(9.99%),Behzad Aghazadeh(9.99%)

11/14 09:36 (美東)

Kymera Therapeutics | SC 13G：超過5%持股股東披露文件-FMR LLC(7.933%),Abigail P. Johnson(7.933%)

11/12 10:38 (美東)

Kymera Therapeutics | SC 13G/A：超過5%持股股東披露文件(修正)-Wellington Management Group LLP(7.17%),Wellington Group Holdings LLP(7.17%)等

11/08 10:55 (美東)

Kymera Therapeutics | S-3ASR：“知名成熟發行人”證券註冊聲明

10/31 08:16 (美東)

Kymera Therapeutics | 10-Q：2024財年三季報

10/31 07:50 (美東)

Kymera Therapeutics | 8-K：Kymera Therapeutics公佈2024年第三季度財務業績並提供業務最新情況

10/31 07:41 (美東)

Kymera Therapeutics | 4：持股變動聲明-董事 Esposito Pamela

09/17 18:25 (美東)

Kymera Therapeutics | 144：擬議出售證券

09/17 16:45 (美東)

Kymera Therapeutics | 4：持股變動聲明-董事 Albers Jeffrey W.

08/26 18:36 (美東)

Kymera Therapeutics | 144：擬議出售證券

08/26 16:37 (美東)

Kymera Therapeutics | 144：擬議出售證券

08/26 16:27 (美東)

Kymera Therapeutics | 4：持股變動聲明-董事 BVF PARTNERS L P/IL

08/22 17:10 (美東)

Kymera Therapeutics | SC 13D/A：超過5%持股股東披露文件(修正)-Baker Bros. Advisors LP(9.3%),Baker Bros. Advisors (GP) LLC(9.3%)等

08/22 16:21 (美東)

Kymera Therapeutics | 4：持股變動聲明-董事 BAKER BROS. ADVISORS LP

08/22 16:05 (美東)

Kymera Therapeutics | 8-K：重大事件

08/20 17:28 (美東)

Kymera Therapeutics | 424B5：募資說明書

08/20 16:34 (美東)

Kymera Therapeutics | 424B5：募資說明書

08/19 16:03 (美東)

Kymera Therapeutics | 10-Q：2024財年二季報

08/07 07:21 (美東)